QUOFENIX subst sèche 300 mg flac 10 pce
7680672390017
CH-67239
J01MA23
08.01.8.
Reimbursement limitations:
QUOFENIX
Pour le traitement des infections bactériennes aiguës de la peau et des tissus mous (IBAPTM) …
1 / 3
google
Details
- Product number
- 6723901
- CPT
- -
- Packaging group
- 10 x 300
- Unit
- mg
- Composition
- Praeparatio cryodesiccata: delafloxacinum 300 mg ut delafloxacinum megluminum, megluminum, sulfobutylbetadexum natricum 2.4 g, dinatrii edetas, natrii hydroxidum, acidum hydrochloridum, pro vitro corresp. natrium 175 mg.
Articles (1)
Quofenix 300 mg, Pulver für ein Konzentrat zur Herstellung einer Infusionslösung
Pulver für ein Konzentrat zur Herstellung einer Infusionslösung
10 x 300
Official Swissmedic V2 data
Additional information from the official database
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
PRC
|
300.0 MG | Substance | Wirkstoff (Principe actif) |
|
PRC
|
- | Substance | WIZUS |
|
PRC
|
- | Substance | HNIDK |
|
PRC
|
2.4 G | Substance | HBESI |
|
PRC
|
- | Substance | HNIDK |
|
PRC
|
- | Substance | HNIDK |
|
PRC
|
- | Substance | HNIDK |
|
PRC
|
175.0 MG | Substance | HBESI |
Reimbursement information
Public price
CHF 761.35
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/12/2021
Authorization holder
A. Menarini GmbH
8050 Zürich
Authorization information
- Swissmedic authorization number
- 67239
- Drug name
- Quofenix, Pulver für ein Konzentrat zur Herstellung einer Infusionslösung
- Galenic form
- PULPI
- ATC Code
- J01MA23
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 28/05/2020
- Authorization expiration date
- 31/12/9999
- IT number
- 08.01.8.
- Domain
- Human medicine
Packaging details
- Description (FR)
- QUOFENIX subst sèche 300 mg flac 10 pce
- Description (DE)
- QUOFENIX Trockensub 300 mg Durchstf 10 Stk
- Market launch
- 28/05/2020
- Narcotic (BTM)
- No